Sort
30,917 grants matching “tumor microenvironment”
Molecular Pathology of Pulmonary Carcinogenesis
$1,122,103Ilona Linnoila · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Examining IL-15 and IL-7 as an immunotherapy agent in cancer and AIDS
$1,121,375Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Modulation of Therapeutic Response
$1,121,091James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment
$1,120,958Jyothi Rengarajan · Emory University · R01 · FY2025 · AI
Emergency Myelopoiesis in the Control of Blood Production
$1,120,635Emmanuelle Passegue · Columbia University Health Sciences · R35 · FY2025 · HL
BAY AREA & ANDERSON TEAM AGAINST ACQUIRED RESISTANCE - U54 PROGRAM (BAATAAR-UP)
$1,119,180Trever G Bivona · University Of California, San Francisco · U54 · FY2022 · CA
TARGETING OVARIAN CANCER TUMOR MICROENVIRONMENT SIGNALING FOR THERAPEUTIC EFFECT
$1,118,811Regents Of The University Of Michigan · · FY2015 · Department of the Army
All-Human Microphysical Model of Metastasis Therapy
$1,118,169Linda G. Griffith · Massachusetts Institute Of Technology · UH2 · FY2012 · TR
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform
$1,117,537Shawn Hingtgen · Univ Of North Carolina Chapel Hill · U01 · FY2024 · TR
Flow Responsive Embolic Agent for the Complete Devascularization of Meningiomas
$1,117,374Quynh P Pham · Arsenal Medical, Inc. · R44 · FY2022 · CA
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,117,299Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Tumor Plasticity
$1,117,200Dario C. Altieri · Wistar Institute · R35 · FY2022 · CA
Tumor Plasticity
$1,117,200Dario C. Altieri · Wistar Institute · R35 · FY2023 · CA
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
$1,116,963Douglas F Nixon · Feinstein Institute For Medical Research · R01 · FY2024 · CA
Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis
$1,116,803Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,116,803Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Biomarkers and Therapeutic Targets in Tumor Microenvironment and Metastasis
$1,116,420Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Tumor Microenvironment in Cancer Progression
$1,116,420Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Cellular In vivo Imaging
$1,115,004Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Biology of Mammary Gland Development and Tumorigenesis
$1,114,511Gilbert Smith · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Cancer cell adaptation to metabolic stress
$1,114,050M. Celeste Simon · University Of Pennsylvania · P01 · FY2013 · CA
A novel monobody-drug conjugate to treat mutant KRas pancreatic cancer.
$1,113,257Craig Patrick Ramirez · Tezcat Laboratories Llc · R44 · FY2025 · CA
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
$1,112,696Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
The Houston Center for Acquired Resistance Research (H-CARR)
$1,112,099Jeffrey Nicholas Myers · University Of Tx Md Anderson Can Ctr · U54 · FY2024 · CA
Molecular diagnosis and outcome prediction in lymphoma
$1,111,940Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA